| GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases SQ Tsai, Z Zheng, NT Nguyen, M Liebers, VV Topkar, V Thapar, ... Nature biotechnology 33 (2), 187-197, 2015 | 2451 | 2015 |
| Crizotinib in ROS1-rearranged non–small-cell lung cancer AT Shaw, SHI Ou, YJ Bang, DR Camidge, BJ Solomon, R Salgia, GJ Riely, ... New England Journal of Medicine 371 (21), 1963-1971, 2014 | 2266 | 2014 |
| Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer JF Gainor, L Dardaei, S Yoda, L Friboulet, I Leshchiner, R Katayama, ... Cancer discovery 6 (10), 1118-1133, 2016 | 1192 | 2016 |
| Anchored multiplex PCR for targeted next-generation sequencing Z Zheng, M Liebers, B Zhelyazkova, Y Cao, D Panditi, KD Lynch, J Chen, ... Nature medicine 20 (12), 1479-1484, 2014 | 916 | 2014 |
| Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma M Snuderl, L Fazlollahi, LP Le, M Nitta, BH Zhelyazkova, CJ Davidson, ... Cancer cell 20 (6), 810-817, 2011 | 819 | 2011 |
| Resensitization to crizotinib by the lorlatinib ALK resistance mutation L1198F AT Shaw, L Friboulet, I Leshchiner, JF Gainor, S Bergqvist, A Brooun, ... New England Journal of Medicine 374 (1), 54-61, 2016 | 551 | 2016 |
| Towards a general-purpose foundation model for computational pathology RJ Chen, T Ding, MY Lu, DFK Williamson, G Jaume, AH Song, B Chen, ... Nature Medicine 30 (3), 850-862, 2024 | 401 | 2024 |
| Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer JJ Lin, VW Zhu, S Yoda, BY Yeap, AB Schrock, I Dagogo-Jack, NA Jessop, ... Journal of Clinical Oncology 36 (12), 1199-1206, 2018 | 339 | 2018 |
| Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke DP Hopkins, PA Briss, CJ Ricard, CG Husten, VG Carande-Kulis, ... American journal of preventive medicine 20 (2), 16-66, 2001 | 335 | 2001 |
| A visual-language foundation model for computational pathology MY Lu, B Chen, DFK Williamson, RJ Chen, I Liang, T Ding, G Jaume, ... Nature Medicine 30 (3), 863-874, 2024 | 284 | 2024 |
| Clinicopathologic Features of Non–Small-Cell Lung Cancer Harboring an NTRK Gene Fusion AF Farago, MS Taylor, RC Doebele, VW Zhu, S Kummar, AI Spira, ... JCO precision oncology 2, 1-12, 2018 | 256 | 2018 |
| Durable clinical response to entrectinib in NTRK1-rearranged non-small cell lung cancer AF Farago, LP Le, Z Zheng, A Muzikansky, A Drilon, M Patel, TM Bauer, ... Journal of Thoracic Oncology 10 (12), 1670-1674, 2015 | 237 | 2015 |
| Unique genetic and survival characteristics of invasive mucinous adenocarcinoma of the lung HS Shim, Z Zheng, M Liebers, YJ Cha, QH Ho, M Onozato, LP Le, ... Journal of Thoracic Oncology 10 (8), 1156-1162, 2015 | 203 | 2015 |
| Germline mutations in oncogene-induced senescence pathways are associated with multiple sessile serrated adenomas MK Gala, Y Mizukami, LP Le, K Moriichi, T Austin, M Yamamoto, ... Gastroenterology 146 (2), 520-529. e6, 2014 | 173 | 2014 |
| Acquired resistance to crizotinib in NSCLC with MET exon 14 skipping RS Heist, LV Sequist, D Borger, JF Gainor, RS Arellano, LP Le, ... Journal of Thoracic Oncology 11 (8), 1242-1245, 2016 | 165 | 2016 |
| Analytical validation of the next-generation sequencing assay for a nationwide signal-finding clinical trial: molecular analysis for therapy choice clinical trial CJ Lih, RD Harrington, DJ Sims, KN Harper, CH Bouk, V Datta, J Yau, ... The Journal of Molecular Diagnostics 19 (2), 313-327, 2017 | 153 | 2017 |
| Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts M Jones, Z Zheng, J Wang, J Dudley, E Albanese, A Kadayifci, ... Gastrointestinal endoscopy 83 (1), 140-148, 2016 | 149 | 2016 |
| EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas RJH Ryan, M Nitta, D Borger, LR Zukerberg, JA Ferry, NL Harris, ... PloS one 6 (12), e28585, 2011 | 149 | 2011 |
| Implementing the DICOM standard for digital pathology MD Herrmann, DA Clunie, A Fedorov, SW Doyle, S Pieper, V Klepeis, ... Journal of pathology informatics 9 (1), 37, 2018 | 145 | 2018 |
| β‐Catenin mutation status and outcomes in sporadic desmoid tumors JT Mullen, TF DeLaney, AE Rosenberg, L Le, AJ Iafrate, W Kobayashi, ... The oncologist 18 (9), 1043-1049, 2013 | 142 | 2013 |
